Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___	O
Chief	O
Complaint:	O
Chest	O
Pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___	O
Cardiac	O
Catheterization	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
female	O
with	O
PMH	O
breast	O
cancer	O
on	O
active	O
chemotherapy,	O
HOCM,	O
HTN,	O
diverticulitis	O
s/p	O
partial	O
colectomy	O
who	O
presents	O
with	O
chest	O
pain.	O
She	O
states	O
that	O
the	O
chest	O
pain	O
began	O
on	O
___	O
around	O
2pm	O
while	O
she	O
was	O
at	O
rest.	O
Nothing	O
made	O
it	O
better	O
or	O
worse.	O
The	O
pain	O
was	O
behind	O
her	O
sternum	O
and	O
radiated	O
to	O
the	O
head,	O
neck,	O
arms,	O
belly	O
and	O
legs.	O
She	O
states	O
she	O
was	O
a	O
little	O
short	O
of	O
breath	O
as	O
well.	O
She	O
denies:	O
lightheadedness,	O
numbness,	O
weakness,	O
bloody	O
cough,	O
nausea,	O
palpitations.	O
She	O
states	O
she	O
has	O
never	O
experienced	O
anything	O
like	O
this	O
before.	O
She	O
states	O
it	O
lasted	O
for	O
many	O
hours	O
over	O
12	O
hours	O
she	O
states	O
but	O
she	O
did	O
not	O
count.	O
In	O
the	O
ED,	O
-	O
Initial	O
vitals:	O
97.0	O
92	O
87/47	O
16	O
95%	O
RA	O
-	O
EKG:	O
sinus	O
rhythm,	O
lateral	O
twi	O
and	O
ST	O
depressions	O
-	O
Labs/studies	O
notable	O
for:	O
Trop-T	O
0.03	O
->	O
0.32,	O
lactate	O
3.7	O
->	O
1.8,	O
WBC	O
15.6,	O
Plts	O
110,	O
___	O
14.0/1.3,	O
PTT	O
22.5,	O
Lipase	O
197,	O
Ph	O
2.6	O
CTA	O
torso	O
showed	O
the	O
following.	O
1.	O
No	O
acute	O
aortic	O
abnormality.	O
No	O
PE.	O
2.	O
Left	O
breast	O
mass	O
measuring	O
up	O
to	O
2.9	O
cm	O
in	O
this	O
patient	O
with	O
known	O
breast	O
cancer.	O
3.	O
Diverticulosis	O
without	O
evidence	O
of	O
diverticulitis.	O
4.	O
Air	O
within	O
the	O
urinary	O
bladder,	O
likely	O
reflecting	O
recent	O
instrumentation	O
CT	B-Intracranial_haemorrhage
head:	B-Intracranial_haemorrhage
No	O
evidence	O
of	O
acute	O
intracranial	B-Intracranial_haemorrhage
abnormality.	O
-	O
Cardiology	O
was	O
consulted:	O
consistent	O
with	O
type	O
I	O
NSTEMI.	O
If	O
no	O
contraindications,	O
agree	O
with	O
ASA,	O
high	O
dose	O
statin,	O
and	O
heparin	O
gtt.	O
Admit	O
to	O
___.	O
Keep	O
NPO	O
after	O
MN	O
for	O
coronary	O
angiography	O
-	O
Patient	O
was	O
given:	O
1	O
L	O
LR	O
-	O
Vitals	O
on	O
transfer:	O
98.2	O
76	O
98/50	O
20	O
95%	O
RA	O
Past	O
Medical	O
History:	O
1.	O
CARDIAC	O
RISK	O
FACTORS	O
-	O
Hypertension	O
2.	O
CARDIAC	O
HISTORY	O
-	O
CABG:	O
None	O
-	O
PERCUTANEOUS	O
CORONARY	O
INTERVENTIONS:	O
None	O
-	O
PACING/ICD:	O
None	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY	O
-	O
Hypertrophic	O
cardiomyopathy	O
-	O
followed	O
by	O
cards	O
-	O
Valvular	O
heart	O
dz	O
(+1AR,	O
+1	O
TR,	O
___	O
-	O
Mildly	O
dilated	O
ascending	O
aorta(4	O
cm)&	O
aortic	O
arch	O
(3.5	O
cm)	O
-	O
___	O
esophagus	O
-	O
Hx	O
of	O
Lower	B-Lower_gastrointestinal_haemorrhage
GI	B-Lower_gastrointestinal_haemorrhage
bleed	B-Lower_gastrointestinal_haemorrhage
___	O
diverticulitis	O
s/p	O
partial	O
colectomy	O
-	O
Osteoporosis	O
-	O
Hx	O
of	O
chronic	O
low	O
back	O
pain	O
___	O
lumbar	O
spondylosis	O
and	O
scoliosis	O
followed	O
by	O
Rheum	O
-	O
Hx	O
of	O
B12	O
deficiency	O
anemia	O
-	O
Hx	O
of	O
alloantibody	O
sp	O
blood	O
transfusion	O
-	O
Hx	O
of	O
onycholysis	O
followed	O
by	O
derm	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
died	O
@	O
___	O
in	O
an	O
accident.	O
Mother	O
died	O
@	O
___	O
of	O
old	O
age.	O
She	O
has	O
one	O
brother	O
with	O
history	O
of	O
CVA	O
and	O
2	O
other	O
siblings	O
in	O
good	O
health.	O
She	O
does	O
not	O
have	O
children.	O
No	O
family	O
history	O
of	O
bleeding	O
disorders,	O
stroke,sudden	O
cardiac	O
death	O
or	O
diabetes.	O
No	O
known	O
hx	O
of	O
malignancy	O
Physical	O
Exam:	O
On	O
Admission:	O
GENERAL:	O
Well-developed,	O
well-nourished.	B-Malnutrition
NAD.	O
Mood,	O
affect	O
appropriate.	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
PERRL,	O
EOMI.	O
Conjunctiva	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
No	O
xanthelasma.	O
NECK:	O
Supple	O
with	O
JVP	O
flat	O
at	O
45	O
degrees	O
CARDIAC:	O
RRR,	O
normal	O
S1,	O
S2.	O
III/VI	O
systolic	O
murmur	O
auscultated.	O
LUNGS:	O
No	O
chest	O
wall	O
deformities,	O
scoliosis	O
or	O
kyphosis.	O
Resp	O
were	O
unlabored,	O
no	O
accessory	O
muscle	O
use.	O
No	O
crackles,	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
NTND.	O
No	O
tenderness.	O
EXTREMITIES:	O
No	O
c/c/e.	O
SKIN:	O
No	O
stasis	O
dermatitis,	O
ulcers,	B-Pressure_injury
scars,	O
or	O
xanthomas.	O
At	O
Discharge:	O
VS:	O
98.0	O
PO	O
128	O
/	O
64	O
87	O
18	O
94%	O
RA	O
GENERAL:	O
Well-developed,	O
well-nourished.	B-Malnutrition
NAD.	O
Mood,	O
affect	O
appropriate.	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
PERRL,	O
EOMI.	O
Conjunctiva	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
No	O
xanthelasma.	O
NECK:	O
Supple	O
with	O
JVP	O
flat	O
at	O
45	O
degrees	O
CARDIAC:	O
RRR,	O
normal	O
S1,	O
S2.	O
III/VI	O
systolic	O
murmur	O
auscultated.	O
LUNGS:	O
No	O
chest	O
wall	O
deformities,	O
scoliosis	O
or	O
kyphosis.	O
Resp	O
were	O
unlabored,	O
no	O
accessory	O
muscle	O
use.	O
No	O
crackles,	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
NTND.	O
No	O
tenderness.	O
EXTREMITIES:	O
No	O
c/c/e.	O
SKIN:	O
No	O
stasis	O
dermatitis,	O
ulcers,	B-Pressure_injury
scars,	O
or	O
xanthomas.	O
ACCESS:	O
Right	O
radial	O
access	O
site	O
soft	O
without	O
hematoma,	O
ecchymosis	O
or	O
drainage.	O
Pertinent	O
Results:	O
___	O
Cardiovascular	O
___	O
MD	O
___	O
___	O
Description	O
___	O
left	O
main,	O
left	O
anterior	O
descending,	O
circumflex	O
and	O
right	O
coronary	O
artery	O
have	O
no	O
angiographically	O
significant	O
coronary	O
abnormalities.	O
___	O
Cardiovascular	O
Transthoracic	O
Echo	O
Report	O
CONCLUSION:	O
The	O
left	O
atrial	O
volume	O
index	O
is	O
SEVERELY	O
increased.	O
The	O
right	O
atrium	O
is	O
mildly	O
enlarged.	O
There	O
is	O
moderate	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
a	O
normal	O
cavity	O
size.	O
There	O
is	O
normal	O
regional	O
left	O
ventricular	O
systolic	O
function.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
hyperdynamic.	O
Quantitative	O
biplane	O
left	O
ventricular	O
ejection	O
fraction	O
is	O
71	O
%	O
(normal	O
54-73%).	O
There	O
is	O
a	O
SEVERE	O
(peak	O
70+	O
mmHg)	O
resting	O
left	O
ventricular	O
outflow	O
tract	O
gradient.	O
Normal	O
right	O
ventricular	O
cavity	O
size	O
with	O
normal	O
free	O
wall	O
motion.	O
Tricuspid	O
annular	O
plane	O
systolic	O
excursion	O
(TAPSE)	O
is	O
normal.	O
The	O
aortic	O
sinus	O
diameter	O
is	O
normal	O
for	O
gender	O
with	O
normal	O
ascending	O
aorta	O
diameter	O
for	O
gender.	O
The	O
aortic	O
arch	O
diameter	O
is	O
normal	O
with	O
a	O
normal	O
descending	O
aorta	O
diameter.	O
There	O
is	O
no	O
evidence	O
for	O
an	O
aortic	O
arch	O
coarctation.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
with	O
mid-systolic	O
closure.	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
There	O
is	O
mild	O
[1+]	O
aortic	O
regurgitation.	O
The	O
mitral	O
valve	O
leaflets	O
appear	O
structurally	O
normal	O
with	O
no	O
mitral	O
valve	O
prolapse.	O
There	O
is	O
valvular	O
systolic	O
anterior	O
motion	O
(___).	O
There	O
is	O
mild	O
[1+]	O
mitral	O
regurgitation.	O
The	O
pulmonic	O
valve	O
leaflets	O
are	O
normal.	O
The	O
tricuspid	O
valve	O
leaflets	O
appear	O
structurally	O
normal.	O
There	O
is	O
physiologic	O
tricuspid	O
regurgitation.	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
a	O
trivial	O
pericardial	O
effusion.	O
IMPRESSION:	O
Symmetric	O
left	O
ventricular	O
hypertrpphy	O
with	O
normal	O
regional	O
and	O
hyperdynamic	O
global	O
systolic	O
function.	O
Valvular	O
systolic	O
anterior	O
motion	O
with	O
severe	O
resting	O
dynamic	O
LVOT	O
gradient.	O
Mild	O
mitral	O
regurgitation.	O
Mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
Mild	O
aortic	O
regurgitation	O
with	O
mildly	O
thickened	O
leaflets.	O
Biatrial	O
enlargement.	O
There	O
findings	O
are	O
c/w	O
hypertrophic	O
obstructive	O
cardiomyopathy.	O
Compared	O
with	O
the	O
prior	O
TTE	O
(images	O
reviewed)	O
of	O
___,	O
the	O
findings	O
are	O
similar.	O
FINDINGS:	O
LEFT	O
ATRIUM	O
(LA)/PULMONARY	O
VEINS:	O
SEVERELY	O
increased	O
LA	O
volume	O
index.	O
RIGHT	O
ATRIUM	O
(RA)/INTERATRIAL	O
SEPTUM/INFERIOR	O
VENA	O
CAVA	O
(IVC):	O
Mildly	O
dilated	O
RA.	O
LEFT	O
VENTRICLE	O
(LV):	O
Moderate	O
symmetric	O
hypertrophy.	O
Normal	O
cavity	O
size.	O
Normal	O
regional	O
systolic	O
function.	O
Hyperdynamic	O
ejection	O
fraction.	O
SEVERE	O
resting	O
outflow	O
tract	O
gradient.	O
RIGHT	O
VENTRICLE	O
(RV):	O
Normal	O
cavity	O
size.	O
Normal	O
free	O
wall	O
motion.	O
Normal	O
tricuspid	O
annular	O
plane	O
systolic	O
excursion	O
(TAPSE).	O
AORTA:	O
Normal	O
sinus	O
diameter	O
for	O
gender.	O
Normal	O
ascending	O
diameter	O
for	O
gender.	O
Normal	O
arch	O
diameter.	O
Normal	O
descending	O
aorta.	O
No	O
coarctation.	O
AORTIC	O
VALVE	O
(AV):	O
Mildly	O
thickend	O
(3)	O
leaflets.	O
Mid-systolic	O
closure.	O
No	O
stenosis.	O
Mild	O
[1+]	O
regurgitation.	O
MITRAL	O
VALVE	O
(MV):	O
Normal	O
leaflets.	O
No	O
systolic	O
prolapse.	O
Valvular	O
___.	O
Mild	O
[1+]	O
regurgitation.	O
PULMONIC	O
VALVE	O
(PV):	O
Normal	O
leaflets.	O
Physiologic	O
regurgitation.	O
TRICUSPID	O
VALVE	O
(TV):	O
Normal	O
leaflets.	O
Physiologic	O
regurgitation.	O
Mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
PERICARDIUM:	O
Trivial	O
effusion.	O
ADDITIONAL	O
FINDINGS:	O
Poor	O
subcostal	O
and	O
suprasternal	O
image	O
quality.	O
___	O
Imaging	O
CT	B-Intracranial_haemorrhage
HEAD	B-Intracranial_haemorrhage
W/O	O
CONTRAST	O
IMPRESSION:	O
No	O
evidence	O
of	O
acute	O
intracranial	B-Intracranial_haemorrhage
abnormality.	O
___	O
Imaging	O
CTA	O
CHEST	O
AND	O
CT	O
ABDOMEN	O
IMPRESSION:	O
1.	O
No	O
acute	O
aortic	O
abnormality.	O
2.	O
Left	O
breast	O
mass	O
measuring	O
up	O
to	O
2.9	O
cm.	O
As	O
per	O
the	O
prior	O
ultrasound,	O
this	O
represents	O
a	O
slight	O
decrease	O
in	O
size.	O
However,	O
findings	O
would	O
be	O
better	O
characterized	O
with	O
mammography	O
or	O
ultrasound.	O
Left	O
axillary	O
lymph	O
nodes	O
measure	O
up	O
to	O
0.6	O
cm.	O
Dilated	O
left	O
atrium	O
and	O
evidence	O
of	O
left	O
ventricular	O
hypertrophy.	O
Please	O
correlate	O
clinically.	O
3.	O
Status	O
post	O
partial	O
colectomy.	O
Extensive	O
diverticulosis	O
without	O
evidence	O
of	O
acute	O
diverticulitis.	O
4.	O
Air	O
within	O
the	O
urinary	O
bladder.	O
Presumably	O
this	O
is	O
from	O
prior	O
catheterization,	O
however	O
recommend	O
clinical	O
correlation.	O
5.	O
Congenital	O
right	O
UPJ	O
obstruction.	O
6.	O
Left	O
lung	O
nodules	O
measuring	O
up	O
to	O
4	O
mm	O
in	O
the	O
left	O
upper	O
lobe.	O
Correlation	O
with	O
priors	O
advised	O
and	O
attention	O
on	O
follow-up	O
in	O
this	O
patient	O
with	O
history	O
of	O
breast	O
cancer.	O
7.	O
2	O
mm	O
right	O
thyroid	O
nodule.	O
No	O
follow-up	O
recommended	O
as	O
per	O
ACR	O
guidelines.	O
___	O
Imaging	O
CHEST	O
(PORTABLE	O
AP)	O
IMPRESSION:	O
No	O
acute	O
findings.	O
LABS:	O
___	O
06:58AM	O
BLOOD	O
WBC-7.1	O
RBC-4.11	O
Hgb-12.5	O
Hct-37.3	O
MCV-91	O
MCH-30.4	O
MCHC-33.5	O
RDW-13.6	O
RDWSD-45.7	O
Plt	O
___	O
___	O
02:51AM	O
BLOOD	O
WBC-9.5	O
RBC-3.65*	O
Hgb-11.0*	O
Hct-33.2*	O
MCV-91	O
MCH-30.1	O
MCHC-33.1	O
RDW-13.4	O
RDWSD-45.1	O
Plt	O
Ct-98*	O
___	O
04:28PM	O
BLOOD	O
WBC-15.6*	O
RBC-3.93	O
Hgb-11.7	O
Hct-35.9	O
MCV-91	O
MCH-29.8	O
MCHC-32.6	O
RDW-13.4	O
RDWSD-45.4	O
Plt	O
___	O
___	O
04:28PM	O
BLOOD	O
Neuts-84*	O
Bands-10*	O
Lymphs-4*	O
Monos-2*	O
Eos-0*	O
Baso-0	O
AbsNeut-14.66*	O
AbsLymp-0.62*	O
AbsMono-0.31	O
AbsEos-0.00*	O
AbsBaso-0.00*	O
___	O
03:00PM	O
BLOOD	O
PTT-37.1*	O
___	O
06:49AM	O
BLOOD	O
PTT-30.1	O
___	O
02:51AM	O
BLOOD	O
___	O
PTT-39.2*	O
___	O
___	O
04:28PM	O
BLOOD	O
___	O
PTT-22.5*	O
___	O
___	O
06:58AM	O
BLOOD	O
Glucose-107*	O
UreaN-10	O
Creat-0.7	O
Na-142	O
K-4.1	O
Cl-106	O
HCO3-20*	O
AnGap-16	O
___	O
02:51AM	O
BLOOD	O
Glucose-100	O
UreaN-11	O
Creat-0.7	O
Na-142	O
K-4.3	O
Cl-109*	O
HCO3-25	O
AnGap-8*	O
___	O
04:28PM	O
BLOOD	O
Glucose-149*	O
UreaN-17	O
Creat-0.9	O
Na-136	O
K-3.6	O
Cl-102	O
HCO3-21*	O
AnGap-13	O
___	O
04:28PM	O
BLOOD	O
ALT-24	O
AST-23	O
CK(CPK)-75	O
AlkPhos-75	O
TotBili-1.3	O
___	O
10:05AM	O
BLOOD	O
cTropnT-0.67*	O
___	O
02:51AM	O
BLOOD	O
cTropnT-0.70*	O
___	O
08:30PM	O
BLOOD	O
cTropnT-0.32*	O
___	O
04:28PM	O
BLOOD	O
cTropnT-0.03*	O
___	O
06:58AM	O
BLOOD	O
Mg-1.9	O
___	O
02:51AM	O
BLOOD	O
Calcium-8.4	O
Phos-1.9*	O
Mg-1.8	O
___	O
04:28PM	O
BLOOD	O
Albumin-3.8	O
Calcium-8.6	O
Phos-2.6*	O
Mg-1.6	O
___	O
04:28PM	O
BLOOD	O
Triglyc-79	O
___	O
06:20PM	O
BLOOD	O
Lactate-1.8	O
___	O
04:38PM	O
BLOOD	O
Lactate-3.7*	O
Creat-0.___SSESSMENT	O
AND	O
PLAN:	O
Ms.	O
___	O
is	O
a	O
___	O
female	O
with	O
PMH	O
breast	O
cancer	O
on	O
active	O
chemotherapy,	O
HOCM,	O
HTN,	O
diverticulitis	O
s/p	O
partial	O
colectomy	O
who	O
presents	O
with	O
chest	O
pain	O
concerning	O
for	O
NSTEMI.	O
#NSTEMI:	O
>10	O
hour	O
episode	O
of	O
chest	O
pain,	O
constant,	O
substernal	O
with	O
radiation	O
to	O
head,	O
neck,	O
arms,	O
and	O
torso.	O
No	O
prior	O
history	O
of	O
chest	O
pain.	O
Of	O
note	O
patient	O
had	O
significant	O
stressors	O
of	O
2	O
family	O
members	O
passing	O
way	O
in	O
mid	O
___.	O
Also,	O
she	O
had	O
rec'd	O
___	O
cycle	O
of	O
chemotherapy	O
for	O
breast	O
CA	O
with	O
neulasta	O
injection	O
on	O
___.	O
Troponin	O
peak	O
at	O
0.7	O
with	O
EKG	O
findings	O
of	O
lateral	O
t	O
wave	O
inversions	O
and	O
ST	O
depressions.	O
Rec'd	O
IV	O
heparin,	O
loaded	O
with	O
ASA,	O
hight	O
dose	O
atorva	O
initiated,	O
and	O
she	O
was	O
admitted.	O
TTE	O
as	O
noted,	O
overall	O
unchanged	O
from	O
prior.	O
Underwent	O
coronary	O
angiography	O
___	O
that	O
revealed	O
no	O
angiographically	O
apparent	O
coronary	O
artery	O
disease.	O
NSTEMI	O
thought	O
to	O
be	O
caused	O
by	O
plaque	O
rupture.	O
Dr.	O
___	O
Neulasta	O
at	O
least	O
a	O
theoretical	O
precipitant	O
of	O
her	O
cardiac	O
event,	O
but	O
does	O
not	O
feel	O
further	O
Neulasta	O
is	O
necessarily	O
contraindicated.	O
-Medical	O
management	O
with	O
aspirin	O
81mg	O
daily,	O
Atorvastatin	O
40mg	O
daily,	O
continue	O
home	O
dose	O
beta	O
blocker	O
-___	O
eval/Cardiac	O
rehab	O
referral	O
-Communicated	O
with	O
oncology	O
provider	O
___	O
___	O
ISSUES:	O
===============	O
#Hypothyropidism:	O
-continue	O
home	O
levothyroxine	O
#HOCM:	O
TTE	O
on	O
___	O
-	O
LVEF	O
69%.	O
Symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function.	O
Valvular	O
___	O
with	O
severe	O
resting	O
LVOT	O
gradient	O
c/w	O
hypertrophic	O
obstructive	O
cardiomyopathy.	O
SBPs	O
in	O
the	O
___	O
but	O
per	O
sheets	O
review	O
in	O
OMR,	O
at	O
her	O
baseline.	O
-continue	O
home	O
dose	O
BB	O
#Breast	O
cancer:	O
___	O
had	O
core	O
biopsy	O
confirming	O
invasive	O
ductal	O
carcinoma,	O
grade	O
2,	O
ER>95%	O
PR<1%	O
HER2	O
+3	O
on	O
IHC,	O
___	O
negative.	O
Clinical	O
Prognostic	O
Stage	O
IIA	O
(AnatomicIIA-cT2N0).	O
Received	O
first	O
round	O
of	O
neoadjuvant	O
chemotherapy	O
with	O
docetaxel	O
and	O
cyclophosphamide	O
on	O
___.	O
Per	O
patient	O
tolerated	O
it	O
well.	O
Also	O
received	O
pegfilgrastim	O
as	O
well.	O
#GERD:	O
-continue	O
home	O
omeprazole	O
#Pyuria:	O
denies	O
any	O
urinary	O
symptoms	O
such	O
as	O
burning	O
or	O
increased	O
urination.	O
U/A	O
with	O
0	O
epis	O
but	O
mod	O
bacteria,	O
34	O
WBC,	O
large	O
leuks	O
and	O
trace	O
blood.	O
-hold	O
off	O
on	O
antibiotics	O
given	O
lack	O
of	O
symptoms	O
-follow	O
up	O
urine	O
culture	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
may	O
be	O
inaccurate	O
and	O
requires	O
futher	O
investigation.	O
1.	O
Ramelteon	O
8	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
2.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
3.	O
Levothyroxine	O
Sodium	O
37.5	O
mcg	O
PO	O
DAILY	O
4.	O
DiphenhydrAMINE	O
50	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
5.	O
azelastine	O
0.05	O
%	O
ophthalmic	O
(eye)	O
BID	O
6.	O
Cyanocobalamin	O
___	O
mcg	O
PO	O
DAILY	O
7.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
8.	O
Acetaminophen	O
___	O
mg	O
PO	O
PRN	O
Pain	O
-	O
Mild	O
9.	O
Cetirizine	O
10	O
mg	O
PO	O
DAILY	O
10.	O
LORazepam	O
0.5	O
mg	O
PO	O
DAILY:PRN	O
anxiety	O
11.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
12.	O
Dexamethasone	O
8	O
mg	O
PO	O
PRN	O
chemo	O
13.	O
Ondansetron	O
4	O
mg	O
PO	O
Q8H:PRN	O
Nausea/Vomiting	O
-	O
First	O
Line	O
14.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q6H:PRN	O
Nausea/Vomiting	O
-	O
First	O
Line	O
15.	O
Multivitamins	O
W/minerals	O
1	O
TAB	O
PO	O
DAILY	O
16.	O
Calcium	O
600	O
+	O
D(3)	O
(calcium	O
carbonate-vitamin	O
D3)	O
600	O
mg(1,500mg)	O
-400	O
unit	O
oral	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
2.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
3.	O
Acetaminophen	O
___	O
mg	O
PO	O
PRN	O
Pain	O
-	O
Mild	O
4.	O
azelastine	O
0.05	O
%	O
ophthalmic	O
(eye)	O
BID	O
5.	O
Calcium	O
600	O
+	O
D(3)	O
(calcium	O
carbonate-vitamin	O
D3)	O
600	O
mg(1,500mg)	O
-400	O
unit	O
oral	O
DAILY	O
6.	O
Cetirizine	O
10	O
mg	O
PO	O
DAILY	O
7.	O
Cyanocobalamin	O
___	O
mcg	O
PO	O
DAILY	O
8.	O
Dexamethasone	O
8	O
mg	O
PO	O
PRN	O
chemo	O
9.	O
DiphenhydrAMINE	O
50	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
10.	O
Levothyroxine	O
Sodium	O
37.5	O
mcg	O
PO	O
DAILY	O
11.	O
LORazepam	O
0.5	O
mg	O
PO	O
DAILY:PRN	O
anxiety	O
12.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
13.	O
Multivitamins	O
W/minerals	O
1	O
TAB	O
PO	O
DAILY	O
14.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
15.	O
Ondansetron	O
4	O
mg	O
PO	O
Q8H:PRN	O
Nausea/Vomiting	O
-	O
First	O
Line	O
16.	O
Prochlorperazine	O
10	O
mg	O
PO	O
Q6H:PRN	O
Nausea/Vomiting	O
-	O
First	O
Line	O
17.	O
Ramelteon	O
8	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
18.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
___	O
Diagnosis:	O
NSTEMI	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
the	O
___	O
___!	O
WHY	O
WAS	O
I	O
IN	O
THE	O
HOSPITAL?	O
==========================	O
-	O
You	O
came	O
to	O
the	O
emergency	O
room	O
because	O
of	O
chest	O
pain.	O
You	O
had	O
an	O
abnormal	O
EKG	O
and	O
abnormal	O
cardiac	O
blood	O
tests,	O
indicating	O
a	O
heart	O
attack	O
(NSTEMI)	O
so	O
you	O
were	O
admitted	O
to	O
the	O
hospital	O
for	O
further	O
care.	O
WHAT	O
HAPPENED	O
IN	O
THE	O
HOSPITAL?	O
==============================	O
-	O
You	O
had	O
a	O
cardiac	O
catheterization	O
test	O
that	O
showed	O
no	O
apparent	O
coronary	O
artery	O
disease.	O
Your	O
heart	O
attack	O
was	O
probably	O
caused	O
by	O
ruptured	O
plaque	O
in	O
a	O
coronary	O
artery.	O
-	O
You	O
had	O
a	O
heart	O
ultrasound	O
(echocardiogram)	O
that	O
reassuringly	O
showed	O
no	O
change	O
in	O
heart	O
function.	O
WHAT	O
SHOULD	O
I	O
DO	O
WHEN	O
I	O
GO	O
HOME?	O
================================	O
-	O
Instructions	O
regarding	O
care	O
of	O
the	O
access	O
site	O
(your	O
right	O
wrist)are	O
included	O
with	O
your	O
discharge	O
information.	O
-	O
Take	O
all	O
of	O
your	O
medications	O
as	O
prescribed	O
(listed	O
below).	O
-	O
Follow	O
up	O
with	O
your	O
doctors	O
as	O
listed	O
below.	O
-	O
It	O
is	O
strongly	O
recommended	O
that	O
you	O
attend	O
a	O
cardiac	O
rehab	O
program	O
in	O
the	O
near	O
future.	O
A	O
referral	O
form	O
was	O
provided	O
to	O
you	O
that	O
lists	O
the	O
locations	O
of	O
these	O
programs.	O
Please	O
bring	O
this	O
with	O
you	O
to	O
your	O
follow	O
up	O
visit	O
with	O
your	O
cardiologist,	O
and	O
they	O
will	O
inform	O
you	O
when	O
it	O
is	O
safe	O
to	O
begin	O
a	O
program.	O
It	O
was	O
a	O
pleasure	O
participating	O
in	O
your	O
care.	O
If	O
you	O
have	O
any	O
urgent	O
questions	O
that	O
are	O
related	O
to	O
your	O
recovery	O
from	O
your	O
hospitalization	O
or	O
are	O
experiencing	O
any	O
symptoms	O
that	O
are	O
concerning	O
to	O
you	O
and	O
you	O
think	O
you	O
may	O
need	O
to	O
return	O
to	O
the	O
hospital,	O
please	O
call	O
the	O
___	O
HeartLine	O
at	O
___	O
to	O
speak	O
to	O
a	O
cardiologist	O
or	O
cardiac	O
nurse	O
practitioner.	O
-Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

